Amelioration of altered airway responses after secondary infection could also be achieved with administration of an IL-13Rα2 fusion protein, blockade of IgE, blockade of IL-33 signaling, or inhibition of STAT6 during the primary infection (165, 176, 180, 181). The gene discussed is IL13RA2; the disease is infection.